ARTICLE | Clinical News
Rapiacta peramivir regulatory update
January 18, 2010 8:00 AM UTC
Japan's Ministry of Health, Labor and Welfare (MHLW) approved an NDA from Shionogi for IV Rapiacta peramivir to treat influenza. The approval triggers a $7 million milestone payment to BioCryst under ...